The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 12,024.00
Ask: 12,028.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.033%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

24 Nov 2021 12:00

Swiss strike deal for COVAX to get 1 mln Moderna doses more quickly

By Stephanie NebehayGENEVA, Nov 24 (Reuters) - Switzerland has become the first country to swap places in the supply queue for COVID-19 vaccines, allowing 1 million doses of the Moderna shot to go first to the COVAX dose-sharing programme, the GAV...

Read more
24 Nov 2021 11:35

Hutchmed China shares rise on Orphathys and Tagrisso Phase 3 study

Hutchmed China shares rise on Orphathys and Tagrisso Phase 3 study

Read more
23 Nov 2021 10:27

LONDON BROKER RATINGS: Hochschild Mining hit with three downgrades

LONDON BROKER RATINGS: Hochschild Mining hit with three downgrades

Read more
22 Nov 2021 14:05

Resumption of India's COVAX vaccine supply delayed by Nepal - sources

KATHMANDU, Nov 22 (Reuters) - The resumption of India supplying COVID-19 vaccines to the global COVAX vaccine-sharing platform after eight months was delayed on Monday when Nepal requested a postponement, two sources told Reuters.The Serum Institu...

Read more
19 Nov 2021 16:13

French health authority recommends COVID booster shot for people over 40

PARIS, Nov 19 (Reuters) - A third dose of the COVID-19 vaccine should be extended to all French people aged over 40, France's health regulator (HAS) said on Friday.So far, the third shot was only available for people older than 65 and the vulnerab...

Read more
19 Nov 2021 11:09

BORSE EUROPA-Scivolano su ritorno timori lockdown

19 novembre (Reuters) - L'azionario europeo inverte la rotta dopo i guadagni iniziali, con i settori ciclici come banche e auto penalizzati dai timori sui potenziali danni economici di nuovi lockdown nella regione per far fronte alla pandemia di ...

Read more
19 Nov 2021 10:34

UPDATE 2-European stocks slammed by lockdown fears, end six-week rally

* Austria reimposes full lockdown* Lagarde reaffirms dovish stance* Hermes soars again index inclusion talk (Adds comments, updates prices throughout)By Anisha Sircar and Shreyashi SanyalNov 19 (Reuters) - European stocks ended in the red on Friday...

Read more
19 Nov 2021 08:45

China's BioKangtai begins first shipment of AstraZeneca's COVID-19 shot

BEIJING, Nov 18 (Reuters) - AstraZeneca Plc's COVID-19 vaccine partner in China, Shenzhen Kangtai Biological Products (BioKangtai), has begun its first shipment of the shot, sending more than four million doses to Indonesia, BioKangtai said on Fr...

Read more
18 Nov 2021 15:03

EU drug regulator eyeing approval of AstraZeneca antibody treatment in 2022

LONDON, Nov 18 (Reuters) - The European Medicines Agency (EMA) intends to conclude the approval process for AstraZeneca's antibody cocktail to prevent and treat COVID-19 at the start of next year, the regulator's head of vaccine strategy said on ...

Read more
18 Nov 2021 14:52

New UK Covid variant may be less likely to cause symptoms, study shows

(Sharecast News) - The fast-spreading variant of Covid-19 recently detected in the UK may be less likely to cause symptoms, the results of new research showed.

Read more
18 Nov 2021 14:29

Biden says U.S. has bought 10 mln doses of Pfizer's COVID-19 antiviral pills

WASHINGTON, Nov 18 (Reuters) - The United States has bought 10 million courses of Pfizer Inc's experimental COVID-19 antiviral drug, President Joe Biden said on Thursday, adding that the delivery of the pills would start by the end of 2021.In a st...

Read more
18 Nov 2021 14:20

AstraZeneca says to seek commercial price for preventive antibody cocktail

FRANKFURT, Nov 18 (Reuters) - AstraZeneca said its antibody cocktail against COVID-19 would - unlike its vaccine - be priced commercially as it negotiates supply contracts with governments around the globe."We are looking at a commercial pricing s...

Read more
18 Nov 2021 10:37

REPEAT: AstraZeneca gets positive results from two trials for Covid-19

REPEAT: AstraZeneca gets positive results from two trials for Covid-19

Read more
18 Nov 2021 09:56

AstraZeneca ges positive results from two AZD7442 trials for Covid-19

AstraZeneca ges positive results from two AZD7442 trials for Covid-19

Read more
18 Nov 2021 07:40

AstraZeneca antibody found to reduce risk of severe Covid-19 by over 80pc

(Sharecast News) - AstraZeneca reported positive findings from recent studies into its Covid-19 antibody treatment on Thursday, reporting that when given to at-risk and immunocompromised patients before exposure to the coronavirus, it reduced the risk of developing severe disease by 83%.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.